Sales & Marketing News | pharmaphorum

News

Trump gives pharma ultimatum on most favoured nation pricing

President Trump has given 17 pharma companies until 29th September to commit to providing lower prices "to every single Medicaid patient."

News

Stéphane Bancel, Moderna's chief executive.

Moderna cuts staff amid operating 'uncertainty'

Moderna will cut another 10% of its workforce as it tries to trim $1.5 billion off its annual costs by 2027.

News

Lilly trumpets heart health data with Mounjaro

Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 drugs for diabetes, with new data for Mounjaro on cardiovascular outcomes.

News

Tidmarsh to stand in for Prasad's role at CBER

Following Vinay Prasad's abrupt departure as CBER director, FDA has asked CDER head George Tidmarsh to take on both roles while a successor is sought.

News

AbbVie files to move Venclexta combo into the CLL front line

AbbVie has filed for FDA approval of a new front-line therapy for chronic lymphocytic leukaemia that it thinks could be 'practice changing."

News

Novo Nordisk slumps as it cuts sales forecast, names new CEO

Novo Nordisk has a new CEO, facing an uphill battle to restore the fortunes of its US business as diabetes and obesity drugs come under pressure.

Trump gives pharma ultimatum on most favoured nation pricing

Moderna cuts staff amid operating 'uncertainty'

Lilly trumpets heart health data with Mounjaro

Tidmarsh to stand in for Prasad's role at CBER

AbbVie files to move Venclexta combo into the CLL front line

Novo Nordisk slumps as it cuts sales forecast, names new CEO

Biogen swoops on Apellis with $5.6bn offer

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks